Shots:

• Pfizer signed a Co-promotion agreement for Exact Sciences Cologuard-first and only FDA-approved non-invasive stool DNA screening test for colorectal cancer(CRC)
•  Pfizer will co-promote Cologuard with Exact from Q4’18- also share total profits and marketing costs equally- Exact will take care of all manufacturing and laboratory operations for Cologuard
• Cologuard is a DNA screening test approved by FDA in Aug 2014- to screen adults- ≥50 years are at risk for CRC

/ article | Ref: Exact Sciences | Image:  PRNewswire